|
시장보고서
상품코드
1754163
장루 백 시장 보고서 : 유형별, 최종사용자별, 지역별(2025-2033년)Colostomy Bags Market Report by Type (Drainable Stoma Bags, Care Accessories), End User (Retail Pharmacies, Hospitals, Outpatient Clinics, Community Healthcare Centers, and Others), and Region 2025-2033 |
||||||
세계의 장루 백 시장 규모는 2024년에 12억 3,560만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 14억 7,090만 달러에 달하며, 2025-2033년의 성장률(CAGR)은 1.9%에 달할 것으로 예측하고 있습니다. 이 시장은 대장암 및 염증성장질환(IBD)의 유병률 증가, 노인 인구 증가, 의료비 지출 증가로 인한 의료비 지출 증가, 가방 디자인 및 소재의 급속한 발전, 장루 관리에 대한 인식과 수용성 증가 등을 배경으로 크게 성장하고 있습니다.
대장암 및 염증성장질환의 유병률 증가
대장암 및 크론병, 궤양성 대장염과 같은 염증성장질환(IBD)의 발병률 증가는 인공항문백 시장 성장의 중요한 촉진제입니다. 대장암은 전 세계에서 세 번째로 흔한 암으로 전체 암 환자의 약 10%를 차지하며, 암 관련 사망 원인 중 두 번째로 높은 비중을 차지합니다. 그 치료는 종종 인공항문과 같은 외과적 개입이 필요합니다. 마찬가지로 IBD가 심한 경우 장의 일부를 절제하고 인공항문을 만드는 수술을 시행하기도 합니다. 미국에서는 매년 7만 명이 새롭게 IBD 진단을 받습니다. 또한 8만 명의 어린이들이 IBD를 앓고 있습니다. 이러한 질환 증가는 장루 백을 통한 피부 보호와 관리, 그리고 장루와 관련된 합병증 예방의 필요성을 강조하고 있습니다.
노인 인구 증가
고령자 인구로의 인구 통계학적 변화는 헬스케어 시스템에 큰 영향을 미칩니다. 나이가 들수록 대장암, 게실염, 기타 노화 관련 소화기 질환과 같이 인공항문백을 사용해야 하는 질병에 걸릴 확률이 높아지며, 2020년에는 60세 이상 인구가 5세 미만 어린이보다 많을 것으로 예상되며, 2015-2050년 사이에 60세 이상 인구가 전 세계 인구에서 차지하는 비율 은 12%에서 22%로 거의 두 배로 증가할 것으로 예측됩니다. 이러한 변화로 인해 수술이 필요한 만성질환의 발생률이 높아져 인공항문 백의 사용으로 이어지고 있습니다. 유럽 건강, 고령화 및 은퇴에 관한 연구(SHARE) 보고서에 따르면 EU 국가 평균적으로 65세 이상의 약 37%가 최소 두 가지 이상의 만성질환을 앓고 있는 것으로 보고되고 있습니다.
의료비 지출 증가 및 상환 정책 개선
의료비 증가, 중산층 인구 증가, 첨단 의료 인프라 구축으로 세계 각국에서 인공항문백의 도입이 진행되고 있습니다. 예를 들어 인도의 보건의료에 대한 공공지출은 '23년 GDP의 2.1%, '22년 2.2%에 달할 전망입니다. 마찬가지로 유럽에서는 2022년 일반 정부 의료비 지출이 1조 2,210억 유로, GDP의 7.7%를 보일 것으로 예측됩니다. 이러한 확대는 병원 및 의료 시설에서 첨단 인공항문 백의 사용과 접근을 용이하게 하여 환자들이 고품질의 제품을 받을 수 있도록 돕고 있습니다. 또한 환자의 경제적 부담을 덜어주는 보험 적용 및 환급 제도와 관련된 유리한 정책이 필요한 수술을 선택하도록 유도하고 있습니다. 미국 인구조사국에 따르면 2022년에는 92.1%, 즉 미국 인구의 3억 4천만 명이 그 해의 어느 시점에 건강 보험에 가입할 것으로 예상하고 있습니다.
The global colostomy bags market size reached USD 1,235.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,470.9 Million by 2033, exhibiting a growth rate (CAGR) of 1.9% during 2025-2033. The market is experiencing significant growth, driven by the increasing prevalence of colorectal cancer and inflammatory bowel diseases (IBD), the rising geriatric population, heightened healthcare expenditure with improved reimbursement policies, rapid advancements in bag design and materials, and the growing awareness and acceptance of ostomy care.
Increasing Prevalence of Colorectal Cancer and Inflammatory Bowel Diseases
The rising incidence of colorectal cancer and inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis is a significant driver for the colostomy bags market growth. Colorectal cancer is the third most common cancer across the globe, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths. Its treatment often necessitates surgical interventions that result in colostomies. Similarly, severe cases of IBD can lead to surgical procedures where a portion of the intestine is removed, and a colostomy is created. As many as 70,000 new cases of IBD are diagnosed in the United States each year. The country also has 80,000 children suffering from IBD. The increased rate of these diseases has highlighted the need for colostomy bags for skin protection and care and to prevent stoma-related complications.
Growing Geriatric Population
The demographic shift toward the geriatric population has profound implications for healthcare systems. As people age, they are more likely to suffer from conditions that necessitate the use of colostomy bags, such as colorectal cancer, diverticulitis, and other age-related gastrointestinal diseases. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. It has been found that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. This shift has resulted in a higher incidence of chronic diseases that may require surgical interventions, leading to the use of colostomy bags. Based on a report by the Survey on Health, Ageing and Retirement in Europe (SHARE), about 37% of people aged 65 and over report having at least two chronic diseases on average across EU countries.
Rising Healthcare Expenditure and Improved Reimbursement Policies
Several countries across the globe are witnessing a hike in the adoption of colostomy bags owing to the rising expenditure on healthcare, the growing population of the middle class, and the establishment of advanced healthcare infrastructures. For instance, India's public expenditure on healthcare reached 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. This expansion is facilitating the availability and accessibility of advanced colostomy bags in hospitals and healthcare facilities to make sure that patients receive high-quality products. Additionally, favorable policies on insurance coverage and reimbursement schemes that reduce the financial burden on patients are encouraging them to opt for necessary surgical procedures. In 2022, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during the year, as per the U.S. Census Bureau.
Drainable stoma bags accounts for the majority of the market share
As per the colostomy bags market trends and analysis, drainable stoma bags hold the largest share. They are highly preferred due to their convenience and cost-effectiveness, particularly for patients who require frequent bag changes. Moreover, they can be emptied and reused multiple times before disposal, making them ideal for individuals with high-output stomas. Besides this, drainable stoma bags offer greater flexibility and ease of use that enhances patient comfort and reduces the overall cost of ostomy care. Additionally, the rising product demand owing to their practicality, as they significantly improve the quality of life for ostomy patients by allowing them to manage their condition more effectively and discreetly, is increasing the colostomy bags market size and share.
Retail pharmacies hold the largest share of the industry
As per the colostomy bags market forecast and research report, retail pharmacies dominated this market due to their widespread accessibility and convenience for patients seeking colostomy care products. They provide a crucial point of distribution, ensuring that patients can easily obtain necessary supplies without the delays that are associated with hospital procurement processes. Retail pharmacies also offer personalized customer service, which is essential for patients who need guidance on product selection and usage, thereby positively influencing the colostomy bags market dynamics and revenue. Additionally, they stock a diverse range of bags, including the latest innovations, ensuring that patients have access to high-quality and varied options.
North America leads the market, accounting for the largest colostomy bags market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America represents the largest regional market for colostomy bags.
According to the colostomy bags market insights and outlook, North America accounted for the largest market share, attributed to several factors, including a high prevalence of colorectal cancer and inflammatory bowel diseases (IBD). Moreover, the advanced healthcare infrastructure, robust medical research, and widespread access to cutting-edge medical technologies, ensuring high-quality care and the availability of innovative colostomy products, is catalyzing the market growth. Additionally, the presence of leading manufacturers and a well-established distribution network that facilitates efficient product supply and availability, is bolstering the colostomy bags demand.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)